These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 17970057)
1. Experimental models for therapeutic studies of transitional cell carcinoma. Gabriel U; Bolenz C; Michel MS Anticancer Res; 2007; 27(5A):3163-71. PubMed ID: 17970057 [TBL] [Abstract][Full Text] [Related]
2. Mouse orthotopic models for bladder cancer research. Chan E; Patel A; Heston W; Larchian W BJU Int; 2009 Nov; 104(9):1286-91. PubMed ID: 19388981 [TBL] [Abstract][Full Text] [Related]
3. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)]. Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Xiao Z; McCallum TJ; Brown KM; Miller GG; Halls SB; Parney I; Moore RB Br J Cancer; 1999 Oct; 81(4):638-46. PubMed ID: 10574249 [TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases. Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419 [TBL] [Abstract][Full Text] [Related]
6. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer. Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall. Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466 [TBL] [Abstract][Full Text] [Related]
13. The application of epigenetic modifiers on the treatment of prostate and bladder cancer. Zhang Z; Karam J; Frenkel E; Sagalowsky A; Hsieh JT Urol Oncol; 2006; 24(2):152-60. PubMed ID: 16520279 [TBL] [Abstract][Full Text] [Related]
15. Modeling human bladder cancer. Ringuette-Goulet C; Bolduc S; Pouliot F World J Urol; 2018 Nov; 36(11):1759-1766. PubMed ID: 29948049 [TBL] [Abstract][Full Text] [Related]
16. Nested variant of transitional cell carcinoma with osseous metaplasia of the urinary bladder: a case report and review of published reports. Neşe N; Kandiloğlu AR; Atesçi YZ Int J Urol; 2007 Apr; 14(4):365-7. PubMed ID: 17470174 [TBL] [Abstract][Full Text] [Related]
17. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder. Jamshidian H; Kor K; Djalali M Urol J; 2008; 5(4):243-7. PubMed ID: 19101898 [TBL] [Abstract][Full Text] [Related]
18. The optimal management of T1G3 bladder cancer. Emiliozzi P; Pansadoro A; Pansadoro V BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891 [No Abstract] [Full Text] [Related]
19. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy. Taweemonkongsap T; Nualyong C; Amornvesukit T; Leewansangtong S; Srinualnad S; Chaiyaprasithi B; Sujijantararat P; Tantiwong A; Soontrapa S World J Surg Oncol; 2008 Jan; 6():3. PubMed ID: 18194580 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of combined therapy in carcinoma of the bladder. Kagan AR; Gilbert HA Cancer Clin Trials; 1978; 1(4):305-6. PubMed ID: 391430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]